湯臣倍健(300146.SZ):2024年銷售費用率預計趨近於近兩年水平
格隆匯3月20日丨湯臣倍健(300146.SZ)於2024年3月19日舉行2023年度投資者業績電話會,就“公司2024年利潤率及銷售費用率的規劃”,公司回覆稱,公司銷售費用率預計趨近於近兩年水平,主要基於以下原因:(1)公司堅持強品牌和強科技戰略,在這方面的投入主要基於公司長期發展需要;(2)公司堅持多品牌全品類全渠道佈局,一定程度分散費用投向,銷售費用率在一段時間內難有下降空間;(3)線上渠道已成為行業最大的渠道,佔比超過一半,線上渠道競爭充分,費用端壓力大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.